Periodic Reporting for period 2 - BRIGHT (Treat severe cases of infection at COV with XAV-19)

The issue addressed in BRIGHT by XENOTHERA is the treatment of coronavirus disease 2019 (COVID19). The goal is to reduce progression of mild to severe disease. Passive antibody therapies with convalescent plasma or monoclonal antibodies have demonstrated efficacy but also...